News & Updates
Filter by Specialty:

High-risk endometrial cancer outcomes not compromised with minimally invasive vs open surgery
In the treatment of endometrial cancer patients with high-risk histology, minimally invasive surgery neither worsens cancer prognosis nor contributes to a significant increase in the risks of recurrence and mortality as compared with open surgery, according to a systematic review and meta-analysis.
High-risk endometrial cancer outcomes not compromised with minimally invasive vs open surgery
27 Jul 2022
Maternal vaccination reduces COVID-19 hospitalization risk in offspring
Full vaccination (two doses) with an mRNA COVID-19 vaccine during pregnancy was associated with a reduced risk of COVID-19-related hospitalization among infants younger than 6 months of age, according to a recent study.
Maternal vaccination reduces COVID-19 hospitalization risk in offspring
27 Jul 2022
UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
In the treatment and prevention of recurrent yeast infection or vulvovaginal candidiasis, oteseconazole performs similarly to standard-of-care fluconazole but better as compared with placebo, as shown in the results of the phase III ultraviolet study.
UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
26 Jul 2022
20-µg hep B vaccine can prevent vertical transmission
Using a 20-µg dose to vaccinate children born to mothers with detectable levels of hepatitis B virus surface antigen (HBsAg) appears to avert vertical transmission, reports a recent China study.
20-µg hep B vaccine can prevent vertical transmission
23 Jul 2022
Pre-eclampsia ups risk of nonsyndromic orofacial clefts
Only pre-eclampsia, among other hypertensive disorders of pregnancy, contributes to a higher risk of nonsyndromic orofacial clefts (NSOFCs) and its subtypes, a study has found.
Pre-eclampsia ups risk of nonsyndromic orofacial clefts
21 Jul 2022
Women hospitalized with COVID-19 suffer from menstrual changes, worse mental health
COVID-19 appears to alter the menstrual cycle and impair mental health in women hospitalized for the disease, a recent study has found.
Women hospitalized with COVID-19 suffer from menstrual changes, worse mental health
21 Jul 2022
Weekly dose-dense CT does not confer survival benefit for ovarian cancer patients
In the final analysis of the phase III ICON8* study, a weekly dose-dense chemotherapy (CT) regimen comprising paclitaxel and carboplatin did not improve survival outcomes in women with epithelial ovarian cancer** compared with the standard first-line (1L) paclitaxel-carboplatin regimen given once every 3 weeks (Q3W).